SNTI
Price
$3.15
Change
-$0.06 (-1.87%)
Updated
Apr 3, 01:57 PM (EDT)
Capitalization
83.47M
VERV
Price
$3.78
Change
-$0.13 (-3.32%)
Updated
Apr 3, 03:04 PM (EDT)
Capitalization
347.19M
34 days until earnings call
Ad is loading...

SNTI vs VERV

Header iconSNTI vs VERV Comparison
Open Charts SNTI vs VERVBanner chart's image
Senti Biosciences
Price$3.15
Change-$0.06 (-1.87%)
Volume$434
Capitalization83.47M
Verve Therapeutics
Price$3.78
Change-$0.13 (-3.32%)
Volume$100
Capitalization347.19M
SNTI vs VERV Comparison Chart
Loading...
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNTI vs. VERV commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNTI is a Hold and VERV is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (SNTI: $3.21 vs. VERV: $3.91)
Brand notoriety: SNTI and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNTI: 31% vs. VERV: 193%
Market capitalization -- SNTI: $83.47M vs. VERV: $347.19M
SNTI [@Biotechnology] is valued at $83.47M. VERV’s [@Biotechnology] market capitalization is $347.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNTI’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 1 green FA rating(s).

  • SNTI’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 1 green, 4 red.
According to our system of comparison, SNTI is a better buy in the long-term than VERV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNTI’s TA Score shows that 4 TA indicator(s) are bullish while VERV’s TA Score has 4 bullish TA indicator(s).

  • SNTI’s TA Score: 4 bullish, 4 bearish.
  • VERV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SNTI is a better buy in the short-term than VERV.

Price Growth

SNTI (@Biotechnology) experienced а -9.58% price change this week, while VERV (@Biotechnology) price change was -27.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.30%. For the same industry, the average monthly price growth was -10.41%, and the average quarterly price growth was -14.40%.

Reported Earning Dates

SNTI is expected to report earnings on Aug 12, 2024.

VERV is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($347M) has a higher market cap than SNTI($83.5M). SNTI YTD gains are higher at: -8.547 vs. VERV (-30.674). SNTI has higher annual earnings (EBITDA): -57.12M vs. VERV (-221.91M). VERV has more cash in the bank: 524M vs. SNTI (10.5M). SNTI has less debt than VERV: SNTI (34.7M) vs VERV (70M). VERV has higher revenues than SNTI: VERV (32.3M) vs SNTI (0).
SNTIVERVSNTI / VERV
Capitalization83.5M347M24%
EBITDA-57.12M-221.91M26%
Gain YTD-8.547-30.67428%
P/E RatioN/AN/A-
Revenue032.3M-
Total Cash10.5M524M2%
Total Debt34.7M70M50%
TECHNICAL ANALYSIS
Technical Analysis
SNTIVERV
RSI
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 11 days ago
74%
Bullish Trend 10 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRSRX48.83N/A
N/A
Putnam Research R
SSEAX11.56N/A
N/A
SEI Screened World Equity Ex-US A (SIIT)
NUGIX33.82N/A
N/A
Nuveen Global Dividend Growth I
TRGLX61.09N/A
N/A
T. Rowe Price Global Stock I
QCLVX31.55N/A
N/A
Federated Hermes MDT Large Cap Value C

SNTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNTI has been loosely correlated with PPBT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if SNTI jumps, then PPBT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNTI
1D Price
Change %
SNTI100%
-1.05%
PPBT - SNTI
54%
Loosely correlated
+1.58%
TCRT - SNTI
47%
Loosely correlated
+29.63%
INBX - SNTI
41%
Loosely correlated
+0.36%
DARE - SNTI
32%
Poorly correlated
+0.69%
PTCT - SNTI
32%
Poorly correlated
+3.80%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with CRSP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-5.44%
CRSP - VERV
54%
Loosely correlated
+3.17%
BEAM - VERV
53%
Loosely correlated
+4.79%
RXRX - VERV
50%
Loosely correlated
+3.83%
NTLA - VERV
48%
Loosely correlated
+9.69%
IVEVF - VERV
46%
Loosely correlated
N/A
More